Suppr超能文献

PTEN/MMAC1/TEP1在原发性前列腺癌中的作用。

PTEN/MMAC1/TEP1 involvement in primary prostate cancers.

作者信息

Pesche S, Latil A, Muzeau F, Cussenot O, Fournier G, Longy M, Eng C, Lidereau R

机构信息

Laboratoire d'Oncogénétique, Centre René Huguenin, St-Cloud, France.

出版信息

Oncogene. 1998 Jun 4;16(22):2879-83. doi: 10.1038/sj.onc.1202081.

Abstract

The PTEN/MMAC1/TEP1 gene, located at 10q23.3, is a tumor suppressor gene responsible for the familial cancer syndromes Cowden disease and Bannayan-Zonana syndrome, and is commonly somatically mutated in several types of cancers. Mutations of the PTEN gene have been found in prostate cancer cell lines and LOH at 10q22-24 in prostate tumors have also been described with a high frequency. To determine the role of this gene in prostate tumorigenesis, we therefore analysed 22 primary tumors for loss of heterozygosity (LOH) within the 10q22-23 region such that tumors hemizygous at those loci may be examined for somatic PTEN mutations. Losses of heterozygosity of at least one locus was found in 12 (55%) of the 22 tumors DNAs. Among these, six tumors exhibited allele loss in the interval between D10S1765 and D10S541 wherein lies the PTEN gene. We searched the entire coding region of PTEN for somatic mutations in these six tumors. One somatic mutation (17%), a 1 bp deletion, was detected in exon 7 of the gene, in one tumor, indicating that somatic mutations of the PTEN gene may occur in primary prostate tumors.

摘要

位于10q23.3的PTEN/MMAC1/TEP1基因是一种肿瘤抑制基因,与家族性癌症综合征考登病和班纳扬-佐纳纳综合征相关,并且在几种癌症中通常发生体细胞突变。在前列腺癌细胞系中已发现PTEN基因突变,并且在前列腺肿瘤中也高频报道了10q22 - 24区域的杂合性缺失(LOH)。为了确定该基因在前列腺肿瘤发生中的作用,我们分析了22例原发性肿瘤在10q22 - 23区域内的杂合性缺失情况,以便对这些位点半合子的肿瘤检测体细胞PTEN突变。在22例肿瘤DNA中,有12例(55%)发现至少一个位点的杂合性缺失。其中,6例肿瘤在位于PTEN基因的D10S1765和D10S541之间的区间表现出等位基因缺失。我们在这6例肿瘤中搜索PTEN的整个编码区域寻找体细胞突变。在其中1例肿瘤的该基因外显子7中检测到1个体细胞突变(17%),为1个碱基缺失,这表明PTEN基因的体细胞突变可能发生在原发性前列腺肿瘤中。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验